Australia · Delayed Price · Currency is AUD Vitrafy Life Sciences Statistics
Total Valuation
ASX:VFY has a market cap or net worth of AUD 293.37 million. The enterprise value is 267.57 million.
| Market Cap | 293.37M |
| Enterprise Value | 267.57M |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:VFY has 76.20 million shares outstanding. The number of shares has increased by 43.38% in one year.
| Current Share Class | 76.20M |
| Shares Outstanding | 76.20M |
| Shares Change (YoY) | +43.38% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 22.90% |
| Owned by Institutions (%) | 1.84% |
| Float | 45.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 80.19 |
| PB Ratio | 7.14 |
| P/TBV Ratio | 7.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 73.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.77 |
| Quick Ratio | 15.31 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -779.15 |
Financial Efficiency
Return on equity (ROE) is -46.29% and return on invested capital (ROIC) is -29.72%.
| Return on Equity (ROE) | -46.29% |
| Return on Assets (ROA) | -27.94% |
| Return on Invested Capital (ROIC) | -29.72% |
| Return on Capital Employed (ROCE) | -40.50% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +131.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +131.52% |
| 50-Day Moving Average | 3.05 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 72.68 |
| Average Volume (20 Days) | 72,093 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:VFY had revenue of AUD 3.66 million and -16.17 million in losses. Loss per share was -0.25.
| Revenue | 3.66M |
| Gross Profit | -5.01M |
| Operating Income | -16.78M |
| Pretax Income | -16.17M |
| Net Income | -16.17M |
| EBITDA | -16.65M |
| EBIT | -16.78M |
| Loss Per Share | -0.25 |
Balance Sheet
The company has 26.10 million in cash and 302,574 in debt, with a net cash position of 25.80 million or 0.34 per share.
| Cash & Cash Equivalents | 26.10M |
| Total Debt | 302,574 |
| Net Cash | 25.80M |
| Net Cash Per Share | 0.34 |
| Equity (Book Value) | 41.11M |
| Book Value Per Share | 0.64 |
| Working Capital | 40.59M |
Cash Flow
In the last 12 months, operating cash flow was -15.77 million and capital expenditures -537,362, giving a free cash flow of -16.31 million.
| Operating Cash Flow | -15.77M |
| Capital Expenditures | -537,362 |
| Depreciation & Amortization | 124,544 |
| Net Borrowing | -89,784 |
| Free Cash Flow | -16.31M |
| FCF Per Share | -0.21 |
Margins
| Gross Margin | -136.86% |
| Operating Margin | -458.58% |
| Pretax Margin | -442.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:VFY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.38% |
| Shareholder Yield | -43.38% |
| Earnings Yield | -5.51% |
| FCF Yield | -5.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for ASX:VFY is 4.61, which is 19.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.61 |
| Price Target Difference | 19.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 197.68% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |